Balanced Propofol in Therapeutic GI Procedures Reap Improved Benefits Over Conventional Sedation

Researchers found balanced propofol sedation, consisting of propofol in combination with midazolam and meperidine, resulted in improved provider and patient satisfaction over conventional sedation while displaying similar adverse events after GI therapeutic procedures, according to a study published in Gastrointestinal Endoscopy.

The study observed 222 patients who underwent either therapeutic EGD or ERCP. Conventional sedation consisted of midazolam and meperidine. Results showed no significant difference in cardiopulmonary complications; however, healthcare provider satisfaction was markedly higher for those who performed the procedures with balanced propofol than those who performed the procedures with conventional sedation. Similarly, patients who received balanced propofol showed greater cooperation.

Read the study about propofol in therapeutic GI procedures.

Read other coverage about propofol:

– A Measure of Safety: Preventing Infection During Medication Administration

– ASA Clarifies Medically Induced Coma Versus Sedation

– Researchers Study Computer-Assisted Personalized Sedation System

Next Up in GI & Endoscopy